{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T06:56:03Z","timestamp":1764053763783},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T00:00:00Z","timestamp":1630281600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T00:00:00Z","timestamp":1630281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s10741-021-10163-0","type":"journal-article","created":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T07:16:50Z","timestamp":1630307810000},"page":"1559-1565","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comprehensive approach to cardiac amyloidosis care: considerations in starting an amyloidosis program"],"prefix":"10.1007","volume":"27","author":[{"given":"Brett W.","family":"Sperry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie A.","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahzad","family":"Raza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie L.","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,30]]},"reference":[{"issue":"11","key":"10163_CR1","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1016\/j.amjcard.2019.08.045","volume":"124","author":"BW Sperry","year":"2019","unstructured":"Sperry BW, Saeed IM, Raza S, Kennedy KF, Hanna M, Spertus JA (2019) Increasing rate of hospital admissions in patients with amyloidosis (from the National Inpatient Sample). Am J Cardiol 124(11):1765\u20131769. https:\/\/doi.org\/10.1016\/j.amjcard.2019.08.045","journal-title":"Am J Cardiol"},{"issue":"11","key":"10163_CR2","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s11886-015-0653-1","volume":"17","author":"MN Vranian","year":"2015","unstructured":"Vranian MN, Sperry BW, Valent J, Hanna M (2015) Emerging advances in the management of cardiac amyloidosis. Curr Cardiol Rep 17(11):100. https:\/\/doi.org\/10.1007\/s11886-015-0653-1","journal-title":"Curr Cardiol Rep"},{"issue":"10","key":"10163_CR3","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1007\/s12325-015-0250-0","volume":"32","author":"I Lousada","year":"2015","unstructured":"Lousada I, Comenzo RL, Landau H, Guthrie S, Merlini G (2015) Light chain amyloidosis: patient experience survey from the Amyloidosis Research Consortium. Adv Ther 32(10):920\u2013928. https:\/\/doi.org\/10.1007\/s12325-015-0250-0","journal-title":"Adv Ther"},{"key":"10163_CR4","doi-asserted-by":"publisher","first-page":"117954682110152","DOI":"10.1177\/11795468211015230","volume":"15","author":"J Nativi-Nicolau","year":"2021","unstructured":"Nativi-Nicolau J, Sarswat N, Fajardo J et al (2021) Best practices in specialized amyloidosis centers in the United States: a survey of cardiologists, nurses, patients, and patient advocates. Clin Med Insights Cardiol 15:11795468211015230. https:\/\/doi.org\/10.1177\/11795468211015230","journal-title":"Clin Med Insights Cardiol"},{"issue":"10","key":"10163_CR5","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.jacc.2016.06.033","volume":"68","author":"M Grogan","year":"2016","unstructured":"Grogan M, Scott CG, Kyle RA et al (2016) Natural history of wild-type transthyretin cardiac amyloidosis and risk stratification using a novel staging system. J Am Coll Cardiol 68(10):1014\u20131020. https:\/\/doi.org\/10.1016\/j.jacc.2016.06.033","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10163_CR6","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1200\/JCO.18.01398","volume":"37","author":"SK Kumar","year":"2019","unstructured":"Kumar SK, Gertz MA, Dispenzieri A (2019) Validation of Mayo Clinic Staging System for light chain amyloidosis with high-sensitivity troponin. J Clin Oncol 37(2):171\u2013173. https:\/\/doi.org\/10.1200\/JCO.18.01398","journal-title":"J Clin Oncol"},{"key":"10163_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s12350-019-01760-6","author":"S Dorbala","year":"2019","unstructured":"Dorbala S, Ando Y, Bokhari S et al (2019) ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging. J Nucl Cardiol. https:\/\/doi.org\/10.1007\/s12350-019-01760-6","journal-title":"J Nucl Cardiol"},{"issue":"9","key":"10163_CR8","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.jacep.2020.04.019","volume":"6","author":"E Donnellan","year":"2020","unstructured":"Donnellan E, Wazni OM, Hanna M et al (2020) Atrial fibrillation in transthyretin cardiac amyloidosis: predictors, prevalence, and efficacy of rhythm control strategies. JACC Clin Electrophysiol 6(9):1118\u20131127. https:\/\/doi.org\/10.1016\/j.jacep.2020.04.019","journal-title":"JACC Clin Electrophysiol"},{"issue":"3","key":"10163_CR9","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002877","volume":"5","author":"BW Sperry","year":"2016","unstructured":"Sperry BW, Vranian MN, Hachamovitch R et al (2016) Subtype-specific interactions and prognosis in cardiac amyloidosis. J Am Heart Assoc 5(3):e002877. https:\/\/doi.org\/10.1161\/JAHA.115.002877","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"10163_CR10","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jacc.2020.11.006","volume":"77","author":"C Nitsche","year":"2021","unstructured":"Nitsche C, Scully PR, Patel KP et al (2021) Prevalence and outcomes of concomitant aortic stenosis and cardiac amyloidosis. J Am Coll Cardiol 77(2):128\u2013139. https:\/\/doi.org\/10.1016\/j.jacc.2020.11.006","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10163_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.14028","volume":"34","author":"JM Griffin","year":"2020","unstructured":"Griffin JM, Chiu L, Axsom KM et al (2020) United network for organ sharing outcomes after heart transplantation for al compared to ATTR cardiac amyloidosis. Clin Transplant 34(10):e14028. https:\/\/doi.org\/10.1111\/ctr.14028","journal-title":"Clin Transplant"},{"issue":"8","key":"10163_CR12","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1182\/blood-2006-03-001164","volume":"108","author":"G Merlini","year":"2006","unstructured":"Merlini G (2006) Stone MJ. Dangerous small B-cell clones Blood 108(8):2520\u20132530. https:\/\/doi.org\/10.1182\/blood-2006-03-001164","journal-title":"Dangerous small B-cell clones Blood"},{"issue":"9","key":"10163_CR13","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1016\/j.mayocp.2020.06.029","volume":"95","author":"S Dasari","year":"2020","unstructured":"Dasari S, Theis JD, Vrana JA et al (2020) Amyloid typing by mass spectrometry in clinical practice: a Comprehensive review of 16,175 samples. Mayo Clin Proc 95(9):1852\u20131864. https:\/\/doi.org\/10.1016\/j.mayocp.2020.06.029","journal-title":"Mayo Clin Proc"},{"issue":"17","key":"10163_CR14","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1016\/j.jacc.2018.07.092","volume":"72","author":"BW Sperry","year":"2018","unstructured":"Sperry BW, Reyes BA, Ikram A et al (2018) Tenosynovial and cardiac amyloidosis in patients undergoing carpal tunnel release. J Am Coll Cardiol 72(17):2040\u20132050. https:\/\/doi.org\/10.1016\/j.jacc.2018.07.092","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10163_CR15","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.mayocp.2016.06.027","volume":"91","author":"E Muchtar","year":"2016","unstructured":"Muchtar E, Derudas D, Mauermann M et al (2016) Systemic immunoglobulin light chain amyloidosis-associated myopathy: presentation, diagnostic pitfalls, and outcome. Mayo Clin Proc 91(10):1354\u20131361. https:\/\/doi.org\/10.1016\/j.mayocp.2016.06.027","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"10163_CR16","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.2215\/CJN.08720811","volume":"7","author":"L Lobato","year":"2012","unstructured":"Lobato L, Rocha A (2012) Transthyretin amyloidosis and the kidney. Clin J Am Soc Nephrol 7(8):1337\u20131346. https:\/\/doi.org\/10.2215\/CJN.08720811","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10163_CR17","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1038\/s41467-021-22876-9","volume":"12","author":"A Huda","year":"2021","unstructured":"Huda A, Casta\u00f1o A, Niyogi A et al (2021) A machine learning model for identifying patients at risk for wild-type transthyretin amyloid cardiomyopathy. Nat Commun 12(1):2725. https:\/\/doi.org\/10.1038\/s41467-021-22876-9","journal-title":"Nat Commun"},{"issue":"38","key":"10163_CR18","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1093\/eurheartj\/ehx350","volume":"38","author":"A Casta\u00f1o","year":"2017","unstructured":"Casta\u00f1o A, Narotsky DL, Hamid N et al (2017) Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement. Eur Heart J 38(38):2879\u20132887. https:\/\/doi.org\/10.1093\/eurheartj\/ehx350","journal-title":"Eur Heart J"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-021-10163-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-021-10163-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-021-10163-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T07:25:59Z","timestamp":1660807559000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-021-10163-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,30]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["10163"],"URL":"https:\/\/doi.org\/10.1007\/s10741-021-10163-0","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,30]]},"assertion":[{"value":"17 August 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}